Table 5: Retreatment between Days 56–90 in clinical Study 7 (Safety Population).

1500 mg IV iron ()1000 mg IV iron () value

(%) patients retreated71 (5.6%)142 (11.1%)

Data on file, Luitpold Pharmaceuticals, Inc.